The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(2-(3,5-Dichlorophenoxy)acetyl)piperazin-1-yl)benzoic acid ID: ALA4519920
PubChem CID: 155542201
Max Phase: Preclinical
Molecular Formula: C19H18Cl2N2O4
Molecular Weight: 409.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cccc(N2CCN(C(=O)COc3cc(Cl)cc(Cl)c3)CC2)c1
Standard InChI: InChI=1S/C19H18Cl2N2O4/c20-14-9-15(21)11-17(10-14)27-12-18(24)23-6-4-22(5-7-23)16-3-1-2-13(8-16)19(25)26/h1-3,8-11H,4-7,12H2,(H,25,26)
Standard InChI Key: WOZCYXSWTTYEKQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
12.3431 -12.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3420 -13.6469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0500 -14.0559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7597 -13.6465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7569 -12.8238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0482 -12.4185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4680 -14.0539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4651 -14.8713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1693 -15.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8788 -14.8725 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8795 -14.0543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1707 -13.6424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5856 -15.2826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5838 -16.0998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2942 -14.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0010 -15.2858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7096 -14.8787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4155 -15.2926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1236 -14.8862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1258 -14.0681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4141 -13.6581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7089 -14.0668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6339 -14.0550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9266 -13.6458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6333 -14.8722 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8302 -15.2967 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.4130 -12.8409 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
10 13 1 0
13 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
2 23 1 0
23 24 2 0
23 25 1 0
19 26 1 0
21 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 409.27Molecular Weight (Monoisotopic): 408.0644AlogP: 3.42#Rotatable Bonds: 5Polar Surface Area: 70.08Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.76CX Basic pKa: 2.40CX LogP: 3.54CX LogD: 0.95Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.82Np Likeness Score: -1.47
References 1. Ragle LE, Palanisamy DJ, Joe MJ, Stein RS, Norman DD, Tigyi G, Baker DL, Parrill AL.. (2016) Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition., 24 (19): [PMID:27544588 ] [10.1016/j.bmc.2016.08.004 ]